Physician Groups React to Report on Pharma Payments to Providers
Specifically addressing formal medical education scenarios, Ralston told HealthLeaders that much of the onus resides on conference organizers to be alert to conflicts of interest and "develop and enforce explicit policies that maintain complete control of program planning, content and delivery."
"Backgrounds have not always been thoroughly vetted and hopefully this information will help those offering educational content develop processes to keep this from happening in the future," he said.
Noted in the study and accompanying article published by ProPublica is that payout findings only covered seven pharmaceutical companies—including giants AstraZeneca, Eli Lilly, Merck and Pfizer—that voluntarily made physician payment information public.
These relationships are expected to come under greater scrutiny as the more than 70 drug companies operating in the United States are forced to release physician payment information by March 2013 in accordance with healthcare reform mandates.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- Readmissions: No Quick Fix to Costly Hospital Challenge
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers